Published Online: Tuesday, November 1, 2005

Iatrogen (Herndon, Va) recently launched RxWise, a personalized, adverse drug reaction (ADR) risk-assessment system contained on a portable USB Flash Drive or accessible through the Internet. RxWise evaluates the potential risk for an ADR by analyzing patients' self-reported or insurance claims-based medical information and verifying it against medications they are already taking. Using sophisticated risk-assessment software, RxWise provides important, personalized information about medications that may cause adverse reactions. The product covers a wide range of prescription and OTC drugs, as well as herbal remedies. With pull-down windows, patients can easily record medical information to create a history of specific drugs being taken, known medical conditions, and drug allergies. After the information is entered into RxWise, a summary of relevant advisories regarding potential risks is displayed immediately. Patients have the ability to easily forward the advisory via e-mail to their pharmacist or physician. The portable RxWise USB Flash Drive retails for $39.95, and the RxWise Internet version retails for $24. For more information, visit www.rxwise.com, or call 800-RxWise4 (800-799-4734).

Latest Articles
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Poor medication adherence is responsible for unnecessary illness, hospitalizations, disability, and premature death, particularly among patients with chronic diseases.
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
The FDA has approved Merck’s supplemental new drug application for single-dose fosaprepitant dimeglumine for injection.
Latest Issues